These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 23147456

  • 1. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, Levenson M, Li L, McCloskey C, Shoaibi A, Wu E, Zornberg G, Hennessy S.
    Arch Intern Med; 2012 Nov 12; 172(20):1582-9. PubMed ID: 23147456
    [Abstract] [Full Text] [Related]

  • 2. Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.
    Dubrall D, Schmid M, Stingl JC, Sachs B.
    PLoS One; 2020 Nov 12; 15(3):e0230632. PubMed ID: 32214375
    [Abstract] [Full Text] [Related]

  • 3. Angioedema related to Angiotensin inhibitors.
    Knecht SE, Dunn SP, Macaulay TE.
    J Pharm Pract; 2014 Oct 12; 27(5):461-5. PubMed ID: 25124378
    [Abstract] [Full Text] [Related]

  • 4. Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.
    Toh S, Reichman ME, Houstoun M, Ding X, Fireman BH, Gravel E, Levenson M, Li L, Moyneur E, Shoaibi A, Zornberg G, Hennessy S.
    Pharmacoepidemiol Drug Saf; 2013 Nov 12; 22(11):1171-7. PubMed ID: 23878013
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G, Döhler B.
    Transplantation; 2014 Feb 15; 97(3):310-5. PubMed ID: 24492421
    [Abstract] [Full Text] [Related]

  • 6. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
    Schlienger RG, Korn JR, Wehler E, Lopez Leon S, Yeaw J.
    Am J Cardiovasc Drugs; 2017 Dec 15; 17(6):465-474. PubMed ID: 28779444
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors.
    Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, Bangalore S.
    Am J Cardiol; 2012 Aug 01; 110(3):383-91. PubMed ID: 22521308
    [Abstract] [Full Text] [Related]

  • 8. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.
    Alharbi FF, Kholod AAV, Souverein PC, Meyboom RH, de Groot MCH, de Boer A, Klungel OH.
    Fundam Clin Pharmacol; 2017 Dec 01; 31(6):676-684. PubMed ID: 28767167
    [Abstract] [Full Text] [Related]

  • 9. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J, Lee S.
    Pharmacotherapy; 2018 Nov 01; 38(11):1095-1105. PubMed ID: 30225928
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists.
    Kyrmizakis DE, Papadakis CE, Liolios AD, Karatzanis AD, Malandrakis S, Skoulakis CE, Bizakis JG, Velegrakis GA.
    Arch Otolaryngol Head Neck Surg; 2004 Dec 01; 130(12):1416-9. PubMed ID: 15611402
    [Abstract] [Full Text] [Related]

  • 11. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC.
    J Nephrol; 2017 Apr 01; 30(2):281-288. PubMed ID: 27485007
    [Abstract] [Full Text] [Related]

  • 12. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.
    Pharmacotherapy; 2018 Jan 01; 38(1):29-41. PubMed ID: 29059475
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
    Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, Meador KJ.
    JAMA Neurol; 2024 Aug 01; 81(8):866-874. PubMed ID: 38884986
    [Abstract] [Full Text] [Related]

  • 14. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K.
    Vnitr Lek; 2010 Feb 01; 56(2):120-6. PubMed ID: 20329582
    [Abstract] [Full Text] [Related]

  • 15. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
    Sarafidis PA, Stafylas PC, Kanaki AI, Lasaridis AN.
    Am J Hypertens; 2008 Aug 01; 21(8):922-9. PubMed ID: 18535536
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
    Reichman ME, Wernecke M, Graham DJ, Liao J, Yap J, Chillarige Y, Southworth MR, Keeton S, Goulding MR, Mott K, Kelman JA.
    Pharmacoepidemiol Drug Saf; 2017 Oct 01; 26(10):1190-1196. PubMed ID: 28722207
    [Abstract] [Full Text] [Related]

  • 17. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL, Odum LE, Whaley-Connell AT.
    Pharmacotherapy; 2013 May 01; 33(5):496-514. PubMed ID: 23576066
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
    Kristensen KE, Torp-Pedersen C, Gislason GH, Egfjord M, Rasmussen HB, Hansen PR.
    Arterioscler Thromb Vasc Biol; 2015 Mar 01; 35(3):733-40. PubMed ID: 25633315
    [Abstract] [Full Text] [Related]

  • 19. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC.
    JAMA Intern Med; 2014 Mar 01; 174(3):347-54. PubMed ID: 24343093
    [Abstract] [Full Text] [Related]

  • 20. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
    Mandilaras V, Bouganim N, Yin H, Asselah J, Azoulay L.
    Br J Cancer; 2017 Jan 03; 116(1):103-108. PubMed ID: 27846200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.